Paper25129481
Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.
Xing L and 14 others. Nat Med, 2014. Cited by 768 papers, by iCite.
Cite this record
ConductScience Library. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Papers, record 25129481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25129481
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alopecia Areata | Major topic |
| Janus Kinases | Major topic |
| Protein Kinase Inhibitors | Major topic |
| T-Lymphocytes, Cytotoxic | Major topic |
| Animals | |
| Gene Expression Profiling | |
| Humans | |
| Mice | |
| Mice, Inbred C3H | |
| Skin |
Source PubMed
Grants12
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| S10 RR027050 | NCRR NIH HHS | United States | S10RR027050 | PubMed and NIH | NIH RePORTER |
| R21 AR061881 | NIAMS NIH HHS | United States | R21AR061881 | PubMed and NIH | NIH RePORTER |
| T32 GM007088 | NIGMS NIH HHS | United States | T32GM007088 | PubMed and NIH | NIH RePORTER |
| P30AR044535 | NIAMS NIH HHS | United States | P30AR044535 | PubMed and NIH | NIH RePORTER |
| T32GM082271 | NIGMS NIH HHS | United States | DP1GM082271 | PubMed and NIH | NIH RePORTER |
| R01 AR056016 | NIAMS NIH HHS | United States | R01AR056016 | PubMed and NIH | NIH RePORTER |
| R21AR061881 | NIAMS NIH HHS | United States | R21AR061881 | PubMed and NIH | NIH RePORTER |
| T32 GM082771 | NIGMS NIH HHS | United States | T32GM082771 | PubMed and NIH | NIH RePORTER |
| R01AR056016 | NIAMS NIH HHS | United States | R01AR056016 | PubMed and NIH | NIH RePORTER |
| P30 AR044535 | NIAMS NIH HHS | United States | P30AR044535 | PubMed and NIH | NIH RePORTER |
| U01 AR067173 | NIAMS NIH HHS | United States | U01AR067173 | PubMed and NIH | NIH RePORTER |
| S10RR027050 | NCRR NIH HHS | United States | S10RR027050 | PubMed and NIH | NIH RePORTER |
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT03694067 | Androgenetic Alopecia and the JAK-STAT Pathway | Background | ClinicalTrials.gov | |
| NCT06157905 | Efficacy and Safety of Oral Tofacitinib in the Treatment of Alopecia Areata | Background | ClinicalTrials.gov | |
| NCT06202560 | Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study | Background | ClinicalTrials.gov |
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 25198048 | Inhibiting Janus kinases to treat alopecia areata. | https://conductscience.org/library/papers/25198048 | PubMed |
| Comment in | 25233992 | Autoimmune disease: Getting to the root of hair loss in alopecia. | https://conductscience.org/library/papers/25233992 | PubMed |
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22375970 | JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22375970 | PubMed |
| 2 | 20843246 | Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20843246 | PubMed |
| 3 | 21959272 | Companies hope for kinase inhibitor JAKpot. | Nat Rev Drug Discov | 2011 | https://conductscience.org/library/papers/21959272 | PubMed |
| 4 | 14630665 | Gene Expression Dynamics Inspector (GEDI): for integrative analysis of expression profiles. | Bioinformatics | 2003 | https://conductscience.org/library/papers/14630665 | PubMed |
| 5 | 16911275 | Interferon-gamma-deficient mice are resistant to the development of alopecia areata. | Br J Dermatol | 2006 | https://conductscience.org/library/papers/16911275 | PubMed |
| 6 | 8929454 | Interleukin-15 induces the expression of mRNAs of cytolytic mediators and augments cytotoxic activities in primary murine lymphocytes. | Cell Immunol | 1996 | https://conductscience.org/library/papers/8929454 | PubMed |
| 7 | 11133738 | Interleukin 15: biology and relevance to human disease. | Blood | 2001 | https://conductscience.org/library/papers/11133738 | PubMed |
| 8 | 24832234 | Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata. | PLoS One | 2014 | https://conductscience.org/library/papers/24832234 | PubMed |
| 9 | 15654992 | Alopecia areata induced in C3H/HeJ mice by interferon-gamma: evidence for loss of immune privilege. | J Invest Dermatol | 2005 | https://conductscience.org/library/papers/15654992 | PubMed |
| 10 | 20926794 | Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis. | J Immunol | 2010 | https://conductscience.org/library/papers/20926794 | PubMed |
| 11 | 15629407 | A 'hairy' privilege. | Trends Immunol | 2005 | https://conductscience.org/library/papers/15629407 | PubMed |
| 12 | 16682498 | Reprogramming of CTLs into natural killer-like cells in celiac disease. | J Exp Med | 2006 | https://conductscience.org/library/papers/16682498 | PubMed |
| 13 | 8006447 | Alopecia areata in aging C3H/HeJ mice. | J Invest Dermatol | 1994 | https://conductscience.org/library/papers/8006447 | PubMed |
| 14 | 18160967 | Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. | J Invest Dermatol | 2008 | https://conductscience.org/library/papers/18160967 | PubMed |
| 15 | 9804341 | Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. | J Invest Dermatol | 1998 | https://conductscience.org/library/papers/9804341 | PubMed |
| 16 | 23396170 | Transcriptional insights into the CD8(+) T cell response to infection and memory T cell formation. | Nat Immunol | 2013 | https://conductscience.org/library/papers/23396170 | PubMed |
| 17 | 15369638 | Interleukin-2 receptor alpha-chain expression in patients with alopecia areata. | Acta Dermatovenerol Croat | 2004 | https://conductscience.org/library/papers/15369638 | PubMed |
| 18 | 16868550 | The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. | Nat Rev Immunol | 2006 | https://conductscience.org/library/papers/16868550 | PubMed |
| 19 | 9421466 | Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. | J Clin Invest | 1998 | https://conductscience.org/library/papers/9421466 | PubMed |
| 20 | 22902830 | Molecular definition of the identity and activation of natural killer cells. | Nat Immunol | 2012 | https://conductscience.org/library/papers/22902830 | PubMed |
Cited by437
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 768 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42953162 | Alopecia areata coexisting with Hashimoto's thyroiditis and Sjögren's syndrome: case report of hair regrowth and selected laboratory changes during combination treatment including tofacitinib. | Front Immunol | 2026 | https://conductscience.org/library/papers/42953162 | PubMed |
| 42927355 | Immune Cells in Hair Follicle Physiology and Pathology. | Clin Cosmet Investig Dermatol | 2026 | https://conductscience.org/library/papers/42927355 | PubMed |
| 42889649 | Hair follicle regeneration technology: from microenvironment regulation to functional reconstruction. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42889649 | PubMed |
| 42884562 | Synbiotic HQP08 Supplementation for Hair Loss and Depressive Symptoms: An Open-Label Pilot Study of Clinical Outcomes and Gut Microbiome Changes. | Nutrients | 2026 | https://conductscience.org/library/papers/42884562 | PubMed |
| 42877598 | Inflammation-fibrosis coupling in androgenetic alopecia: evidence and mechanistic hypotheses for progressive hair follicle miniaturization. | Front Immunol | 2026 | https://conductscience.org/library/papers/42877598 | PubMed |
| 42876461 | Long-term upadacitinib treatment in a patient with atopic dermatitis, bullous pemphigoid, and alopecia areata: a case report and review of the literature. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42876461 | PubMed |
| 42825997 | Monitoring the Response to JAK Inhibitor Treatment in Alopecia Areata Using Reflectance Confocal Microscopy and Videotrichoscopy: A 60-Week Observational Study. | Dermatol Ther (Heidelb) | 2026 | https://conductscience.org/library/papers/42825997 | PubMed |
| 42824678 | Case Reports of Alopecia Areata Associated With Apical Periodontitis. | Case Rep Dent | 2026 | https://conductscience.org/library/papers/42824678 | PubMed |
| 42824469 | JAK Inhibitors for Alopecia Areata: Approved Therapies, Efficacy, and Unanswered Questions. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42824469 | PubMed |
| 42807149 | Treatment of concomitant alopecia areata and systemic lupus erythematosus with ivarmacitinib: a case report and literature review. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42807149 | PubMed |
| 42769928 | Evolving role of CD8+ tissue-resident memory T cells in autoimmune and immune mediated inflammatory diseases: linking pathogenesis to therapeutic approaches. | Front Immunol | 2026 | https://conductscience.org/library/papers/42769928 | PubMed |
| 42724161 | Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42724161 | PubMed |
| 42713429 | Alopecia management from a comparative perspective: pharmacological and pharmaceutical insights in humans, dogs, and cats. | Front Vet Sci | 2026 | https://conductscience.org/library/papers/42713429 | PubMed |
| 42708150 | Effectiveness and Safety Profile of Oral Tofacitinib in Alopecia Areata: An Observational Study from a Tertiary Hospital. | Indian J Dermatol | 2026 | https://conductscience.org/library/papers/42708150 | PubMed |
| 42707815 | IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42707815 | PubMed |
| 42682781 | Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review. | Clin Case Rep | 2026 | https://conductscience.org/library/papers/42682781 | PubMed |
| 42656655 | Alopecia areata patients are associated with increased risk of glaucoma: a multicenter, retrospective cohort study. | Front Immunol | 2026 | https://conductscience.org/library/papers/42656655 | PubMed |
| 42649169 | Cross-species comparative spatial transcriptomics of hair follicle-T cell interactions identifies conserved drivers of cutaneous lupus erythematosus skin disease and associated hair loss. | Nat Commun | 2026 | https://conductscience.org/library/papers/42649169 | PubMed |
| 42616344 | Alopecia Areata: Current and Emerging Therapies. | Drugs | 2026 | https://conductscience.org/library/papers/42616344 | PubMed |
| 42587228 | S100 signaling in hair follicle biology: emerging mechanistic insights and therapeutic opportunities. | J Mol Histol | 2026 | https://conductscience.org/library/papers/42587228 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data6
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25129481
GET https://conductscience.org/api/papers/v1/25129481/references?page=2